Tregs and miRNAs in Breast Milk: See if breast milk miRNAs influence infant immune cells and food tolerance
Official title: Immunoregulatory Factors in Human Breast Milk: Relationship Between Regulatory T Cells (Tregs), miRNAs and Food Tolerance
Run by Istanbul University · NCT07744373 · Data updated 2026-11-12
This observational study tests whether immune-regulating miRNAs in breast milk relate to the development of infant food tolerance via regulatory T cells.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Days to 9 Months |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Istanbul University Academic / other |
| Locations | 2 sites (Istanbul and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | August 4, 2026 |
| Trial ID | NCT07744373 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are lactating mothers and their term-born infants up to 9 months old who are exclusively breastfed for the first 6 months and consent to serial milk sampling.
✕Probably not a fit
Premature infants, non-exclusively breastfed infants, or those with major congenital or chronic illnesses may not derive direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective study will collect breast milk at several postnatal time points (colostrum, days 10-15, and months 1, 4, 6, and/or 9) and a single infant blood sample at 6-9 months to explore miRNAs associated with regulatory T cells. Researchers will analyze breast milk and infant blood for regulatory T cell–related miRNAs and their target genes, and will relate these findings to the infant’s food tolerance development. Laboratory work will include RNA isolation from milk, molecular analyses, and immunologic/cytometric assessments, performed under standardized sample handling. The study aims to identify temporal patterns of miRNA expression and potential links to immune regulation and food tolerance outcomes.
Why it matters
Potential benefit: If successful, findings could improve understanding of how breast milk components influence infant immune development and food tolerance.
How similar studies have gone: Previous work has shown breast milk miRNAs can modulate immune development in infants, but this study explores specific Treg-related miRNAs and longitudinal patterns in relation to food tolerance.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Lactating mothers and their infants attending the Child Health and Diseases Clinic at Istanbul University Faculty of Medicine, or the Child Health and Diseases Clinic at Esencan Hospital. 2. Infants who are exclusively breastfed for the first 6 months. 3. Mothers willing to provide breast milk samples at multiple time points (colostrum, transitional milk, and mature milk at 1, 4, 6, and/or 9 months postpartum). 4. Infants aged 0-9 months, born at term (≥37 weeks gestation) with no major congenital anomalies or chronic illnesses. 5. Mothers and infants who provide informed consent for participation in the study. Exclusion Criteria: 1. Infants who are not exclusively breastfed for the first 6 months. 2. Infants with chronic illnesses or diagnosed immunodeficiency, metabolic, or gastrointestinal disorders. 3. Mothers who are unable or unwilling to provide informed consent. 4. Mothers with chronic illnesses or immunological disorders that may affect breast milk composition.
Where it's running
-
Child Health and Diseases Clinic, Esencan Hospital
Istanbul, Turkey (Türkiye) Recruiting -
İstanbul University İstanbul Medical Faculty Department of Pediatrics Division of Social Pediatrics
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Gonca Keskindemirci, MD, PhD
- Email: keskindemirci@hotmail.com
- Phone: 0905324934651
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How a mother's immune system accepts pregnancy in the first trimester
We will test how the immune system changes in the first trimester in people undergoing IVF to see which immune patterns support implantation and help prevent early miscarriage.
-
Train the immune system to accept a living-donor liver so you may stop lifelong anti-rejection drugs
This test gives donor stem cells plus a short conditioning treatment to people with HLA-matched living-donor liver transplants to see if they can safely stop long-term immunosuppressive drugs.
-
Kidney transplant with donor vertebral body marrow to promote engraftment
This study tests whether giving bone marrow cells from the donor at the time of a deceased donor kidney transplant is safe and feasible in adults with end-stage kidney disease.
-
Eliminating immunosuppressive drugs in kidney transplant recipients using blood stem cell transplantation.
This study is testing whether kidney transplant patients can safely stop taking their immunosuppressive drugs by using a special treatment with blood stem cells.
-
Effects of Aronia Juice on Immune System and Depression
This study is testing whether drinking aronia juice can boost the immune system and help people with depression feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.